Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group (2020)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.3332/ecancer.2020.1048
- Subjects: COVID-19; NEOPLASIAS; SISTEMA DE SAÚDE; RADIOTERAPIA; PÂNCREAS; ESÔFAGO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Ecancermedicalscience
- ISSN: 1754-6605
- Volume/Número/Paginação/Ano: v. 14, article ID 1048, 16p, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RIECHELMANN, Rachel et al. Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group. Ecancermedicalscience, v. 14, 2020Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2020.1048. Acesso em: 04 fev. 2026. -
APA
Riechelmann, R., Peixoto, R. D. 'A., Fernandes, G. D. S., Weschenfelder, R. F., Prolla, G., Rocha Filho, D., et al. (2020). Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group. Ecancermedicalscience, 14. doi:10.3332/ecancer.2020.1048 -
NLM
Riechelmann R, Peixoto RD'A, Fernandes GDS, Weschenfelder RF, Prolla G, Rocha Filho D, Andrade AC, Crosara M, Rego JFM, Hoff PMG. Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group [Internet]. Ecancermedicalscience. 2020 ; 14[citado 2026 fev. 04 ] Available from: https://doi.org/10.3332/ecancer.2020.1048 -
Vancouver
Riechelmann R, Peixoto RD'A, Fernandes GDS, Weschenfelder RF, Prolla G, Rocha Filho D, Andrade AC, Crosara M, Rego JFM, Hoff PMG. Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group [Internet]. Ecancermedicalscience. 2020 ; 14[citado 2026 fev. 04 ] Available from: https://doi.org/10.3332/ecancer.2020.1048 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
- Quimioterapia sistemica neoadjuvante em câncer epitelial avançado de ovário/peritôneo/tuba uterina: estratégia para obtenção de citorredução ótima
Informações sobre o DOI: 10.3332/ecancer.2020.1048 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
